Medications

Turing reneges on drug price cut, rival's version sells well

After weeks of criticism from patients, doctors and other drugmakers for hiking a life-saving medicine's price more than fifty-fold, Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price.

Neuroscience

Challenges remain in HIV care in Africa

Barriers to diagnosis and lack of access to modern medications have combined to place caregivers and HIV-positive patients in sub-Saharan Africa between a rock and a hard place. A new study shows that physicians are often ...

HIV & AIDS

Computer models predict how patients will respond to HIV drugs

Results of a study published online in the Journal of Antimicrobial Chemotherapy today (Thursday), demonstrate that computer models can predict how HIV patients whose drug therapy is failing will respond to a new treatment. ...

HIV & AIDS

Stigma for Central America's HIV-positive kids

Four-year-old Carlos, who makes a lengthy trip every two weeks with his teenage aunt to a special clinic in El Salvador's capital, has no notion of the cruel stigma that comes with his HIV diagnosis.

HIV & AIDS

Can specialized HIV community pharmacies improve treatment?

Community pharmacies with specially trained staff to provide HIV services can help HIV-infected individuals be more compliant with their essential antiviral drug regimens and hence improve patient outcomes. Users of HIV-specialized ...

HIV & AIDS

HIV genotype unneeded in new treatment computer modeling

New computer models described today in the Journal of Antimicrobial Chemotherapy predict how patients whose HIV therapy is failing will respond to any new combination of drugs, without the need for an HIV genotype: a test ...

page 26 from 31